The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...
NICE has assessed 3 implantable cardiac monitors to help the NHS decide whether to use them. These monitors are called Reveal LINQ, Confirm Rx and BioMonitor 2‑AF. An implantable cardiac monitor is a ...
Please provide your email address to receive an email when new articles are posted on . Medtronic announced its artificial intelligence algorithm technology received market clearance from the FDA to ...
SAN FRANCISCO--(BUSINESS WIRE)--WearLinq, a leading provider of wearable health monitoring and diagnosis solutions, today announced the acquisition of AMI Cardiac Monitoring, LLC, an established ...